Tralement is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by American Regent, Inc.. The primary component is Zinc Sulfate; Cupric Sulfate; Manganese Sulfate; Selenious Acid.
| Product ID | 0517-9305_00f9d21e-cdcf-4de5-aecc-4c4c3de50353 |
| NDC | 0517-9305 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tralement |
| Generic Name | Trace Elements Injection 4 |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-09-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209376 |
| Labeler Name | American Regent, Inc. |
| Substance Name | ZINC SULFATE; CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID |
| Active Ingredient Strength | 3 mg/mL; mg/mL; ug/mL; ug/mL |
| Pharm Classes | Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-09-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0517-9305 | Tralement | Trace Elements Injection 4 |
| 0517-9302 | Multrys | Trace Elements Injection 4 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRALEMENT 88181165 not registered Live/Pending |
Luitpold Pharmaceuticals, Inc. 2018-11-05 |